218 related articles for article (PubMed ID: 18826559)
1. Design of treatment trials in irritable bowel syndrome: opioid agonists and atypical benzodiazepine antagonists.
Mangel AW; Fehnel SE
Neurogastroenterol Motil; 2008 Oct; 20(10):1086-93. PubMed ID: 18826559
[TBL] [Abstract][Full Text] [Related]
2. Irritable bowel syndrome: new pharmaceutical approaches to treatment.
Farthing MJ
Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):461-71. PubMed ID: 10580922
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.
Mangel AW; Bornstein JD; Hamm LR; Buda J; Wang J; Irish W; Urso D
Aliment Pharmacol Ther; 2008 Jul; 28(2):239-49. PubMed ID: 18466359
[TBL] [Abstract][Full Text] [Related]
4. Evolution of clinical trials for irritable bowel syndrome: issues in end points and study design.
Trentacosti AM; He R; Burke LB; Griebel D; Kennedy DL
Am J Gastroenterol; 2010 Apr; 105(4):731-5. PubMed ID: 20372121
[TBL] [Abstract][Full Text] [Related]
5. Asimadoline in the treatment of irritable bowel syndrome.
Mangel AW; Williams VS
Expert Opin Investig Drugs; 2010 Oct; 19(10):1257-64. PubMed ID: 20809870
[TBL] [Abstract][Full Text] [Related]
6. [How can an effective drug to treat irritable bowel syndrome be successfully developed?].
Duracinsky M; Chassany O
Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S26-34. PubMed ID: 19303535
[TBL] [Abstract][Full Text] [Related]
7. Personal view: adequate relief as a primary endpoint in irritable bowel syndrome.
Mangel AW
Aliment Pharmacol Ther; 2006 Apr; 23(7):879-81. PubMed ID: 16573790
[TBL] [Abstract][Full Text] [Related]
8. Serotonergic agents and the irritable bowel syndrome: what goes wrong?
Spiller R
Curr Opin Pharmacol; 2008 Dec; 8(6):709-14. PubMed ID: 18672092
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study.
Brennan BP; Fogarty KV; Roberts JL; Reynolds KA; Pope HG; Hudson JI
Hum Psychopharmacol; 2009 Jul; 24(5):423-8. PubMed ID: 19548294
[TBL] [Abstract][Full Text] [Related]
10. Drug development and IBS drugs: experience from the past, current challenges, and proposal for the future.
Camilleri M
Curr Opin Pharmacol; 2008 Dec; 8(6):671-6. PubMed ID: 18588997
[TBL] [Abstract][Full Text] [Related]
11. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents.
Bahar RJ; Collins BS; Steinmetz B; Ament ME
J Pediatr; 2008 May; 152(5):685-9. PubMed ID: 18410774
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of probiotics in IBS.
Quigley EM
J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S85-90. PubMed ID: 18542036
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic targets].
Bueno L
Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S59-67. PubMed ID: 19303540
[TBL] [Abstract][Full Text] [Related]
14. [Tegaserod in treatment of women with irritable bowel syndrome].
Munck LK; Ainsworth MA
Ugeskr Laeger; 2007 Jun; 169(23):2190-2. PubMed ID: 17592683
[TBL] [Abstract][Full Text] [Related]
15. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
Camilleri M
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
[TBL] [Abstract][Full Text] [Related]
16. New developments in the treatment of irritable bowel syndrome.
De Schryver AM; Samsom M
Scand J Gastroenterol Suppl; 2000; (232):38-42. PubMed ID: 11232489
[TBL] [Abstract][Full Text] [Related]
17. New and emerging treatments for irritable bowel syndrome and functional dyspepsia.
Talley NJ
Expert Opin Emerg Drugs; 2002 May; 7(1):91-8. PubMed ID: 15989538
[TBL] [Abstract][Full Text] [Related]
18. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
[TBL] [Abstract][Full Text] [Related]
19. Irritable bowel syndrome and bloating.
Hasler WL
Best Pract Res Clin Gastroenterol; 2007; 21(4):689-707. PubMed ID: 17643909
[TBL] [Abstract][Full Text] [Related]
20. Irritable bowel syndrome: new and emerging therapies.
Harris LA; Chang L
Curr Opin Gastroenterol; 2006 Mar; 22(2):128-35. PubMed ID: 16462168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
